Advertisement

Telemedicine and Diabetes

  • Sylvia FrancEmail author
Chapter

Abstract

Among the chronic diseases, diabetes is especially amenable to remote monitoring by telemedicine. Further, diabetology is the leading medical specialty in terms of volume of publications regarding telemedicine in Medline [1]. While the value of telemedicine has already been demonstrated in screening for diabetic retinopathy and/or follow-up of diabetic foot lesions, most of the studies in telemedicine with regard to diabetology continue to focus on remote blood glucose measurement via telemonitoring. In this case, patients transmit the data necessary for their follow-up, either automatically or manually, to a healthcare professional, who then interprets them remotely and sends back comments to the patients by text message, email or teleconsultation (Fig. 9.1a). The prominence of telemonitoring is partly due to the data transmission capacity of technologies, which facilitates the monitoring of clinical and laboratory parameters and the transmission of appropriate alerts. However, such systems have their limitations: they can be extremely time-consuming for healthcare providers who must analyse the data, and the time lag means that the comments are generally of little practical value to patients. A more elaborate form of telemedicine however is currently being developed with the aim not only of transmitting data but also of processing this data and enabling the caregiver to provide targeted assistance (Fig. 9.1b) [2]. This form of telemedicine is now moving out of the experimental stage and towards large-scale development and integration in patient care.

References

  1. 1.
    Wootton R. Twenty years of telemedicine in chronic disease management—an evidence synthesis. J Telemed Telecare. 2012;18(4):211–20.CrossRefGoogle Scholar
  2. 2.
    Klonoff DC, True MW. The missing element of telemedicine for diabetes: decision support software. J Diabetes Sci Technol. 2009;3(5):996–1001.CrossRefGoogle Scholar
  3. 3.
    Farmer A, Gibson OJ, Tarassenko L, Neil A. A systematic review of telemedicine interventions to support blood glucose self-monitoring in diabetes. Diabet Med. 2005;22(10):1372–8.CrossRefGoogle Scholar
  4. 4.
    Verhoeven F, van Gemert-Pijnen L, Dijkstra K, Nijland N, Seydel E, Steehouder M. The contribution of teleconsultation and videoconferencing to diabetes care: a systematic literature review. J Med Internet Res. 2007;9(5):e37.CrossRefGoogle Scholar
  5. 5.
    Polisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K. Home telehealth for diabetes management: a systematic review and meta-analysis. Diabetes Obes Metab. 2009;11(10):913–30.CrossRefGoogle Scholar
  6. 6.
    Marcolino MS, Maia JX, Alkmim MBM, Boersma E, Ribeiro AL. Telemedicine application in the care of diabetes patients: systematic review and meta-analysis. PLoS One. 2013;8(11):e79246.CrossRefGoogle Scholar
  7. 7.
    Liang X, Wang Q, Yang X, Cao J, Chen J, Mo X, et al. Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. Diabet Med. 2011;28(4):455–63.CrossRefGoogle Scholar
  8. 8.
    Su D, Zhou J, Kelley MS, Michaud TL, Siahpush M, Kim J, et al. Does telemedicine improve treatment outcomes for diabetes? A meta-analysis of results from 55 randomized controlled trials. Diabetes Res Clin Pract. 2016;116:136–48.CrossRefGoogle Scholar
  9. 9.
    Oh J-A, Kim H-S, Yoon K-H, Choi E-S. A telephone-delivered intervention to improve glycemic control in type 2 diabetic patients. Yonsei Med J. 2003;44(1):1–8.CrossRefGoogle Scholar
  10. 10.
    Holmen H, Torbjørnsen A, Wahl AK, Jenum AK, Småstuen MC, Arsand E, et al. A mobile health intervention for self-management and lifestyle change for persons with type 2 diabetes: Part 2. One-year results from the Norwegian Randomized Controlled Trial RENEWING HEALTH. JMIR Mhealth Uhealth. 2014;2(4):e57.CrossRefGoogle Scholar
  11. 11.
    Wu L, Forbes A, Griffiths P, Milligan P, While A. Telephone follow-up to improve glycaemic control in patients with type 2 diabetes: systematic review and meta-analysis of controlled trials. Diabet Med. 2010;27(11):1217–25.CrossRefGoogle Scholar
  12. 12.
    Walker EA, Shmukler C, Ullman R, Blanco E, Scollan-Koliopoulus M, Cohen HW. Results of a successful telephonic intervention to improve diabetes control in urban adults: a randomized trial. Diabetes Care. 2011;34(1):2–7.CrossRefGoogle Scholar
  13. 13.
    Young RJ, Taylor J, Friede T, Hollis S, Mason JM, Lee P, et al. Pro-active call center treatment support (PACCTS) to improve glucose control in type 2 diabetes: a randomized controlled trial. Diabetes Care. 2005;28(2):278–82.CrossRefGoogle Scholar
  14. 14.
    Piette JD, Weinberger M, McPhee SJ, Mah CA, Kraemer FB, Crapo LM. Do automated calls with nurse follow-up improve self-care and glycemic control among vulnerable patients with diabetes? Am J Med. 2000;108(1):20–7.CrossRefGoogle Scholar
  15. 15.
    Bellazzi R, Larizza C, Montani S, Riva A, Stefanelli M, d’Annunzio G, et al. A telemedicine support for diabetes management: the T-IDDM project. Comput Methods Prog Biomed. 2002;69(2):147–61.CrossRefGoogle Scholar
  16. 16.
    Shea S, Weinstock RS, Teresi JA, Palmas W, Starren J, Cimino JJ, et al. A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus: 5 year results of the IDEATel Study. J Am Med Inform Assoc. 2009;16(4):446–56.CrossRefGoogle Scholar
  17. 17.
    Shea S, Weinstock RS, Starren J, Teresi J, Palmas W, Field L, et al. A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus. J Am Med Inform Assoc. 2006;13(1):40–51.CrossRefGoogle Scholar
  18. 18.
    L’Esperance ST, Perry DJ. Assessing advantages and barriers to telemedicine adoption in the practice setting: a MyCareTeam(TM) exemplar. J Am Assoc Nurse Pract. 2016;28(6):311–9.PubMedGoogle Scholar
  19. 19.
    McMahon GT, Gomes HE, Hickson Hohne S, Hu TM-J, Levine BA, Conlin PR. Web-based care management in patients with poorly controlled diabetes. Diabetes Care. 2005;28(7):1624–9.CrossRefGoogle Scholar
  20. 20.
    Lim S, Kang SM, Shin H, Lee HJ, Won Yoon J, Yu SH, et al. Improved glycemic control without hypoglycemia in elderly diabetic patients using the ubiquitous healthcare service, a new medical information system. Diabetes Care. 2011;34(2):308–13.CrossRefGoogle Scholar
  21. 21.
    Quinn CC, Shardell MD, Terrin ML, Barr EA, Ballew SH, Gruber-Baldini AL. Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care. 2011;34(9):1934–42.CrossRefGoogle Scholar
  22. 22.
    Bentley CL, Otesile O, Bacigalupo R, Elliott J, Noble H, Hawley MS, et al. Feasibility study of portable technology for weight loss and HbA1c control in type 2 diabetes. BMC Med Inform Decis Mak. 2016;16:92.CrossRefGoogle Scholar
  23. 23.
    Daoudi A, Joubert M, Franc S, Fagour C, Benhamou PY, Reznik Y, et al. A smartphone for adjustment of basal insulin dose and for coaching: benefits in terms of glycaemic control for type 2 diabetes patients. Barcelona, Spain: EASD; 2013.Google Scholar
  24. 24.
    The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86.CrossRefGoogle Scholar
  25. 25.
    Thompson DM, Kozak SE, Sheps S. Insulin adjustment by a diabetes nurse educator improves glucose control in insulin-requiring diabetic patients: a randomized trial. CMAJ. 1999;161(8):959–62.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Benhamou P-Y, Melki V, Boizel R, Perreal F, Quesada J-L, Bessieres-Lacombe S, et al. One-year efficacy and safety of Web-based follow-up using cellular phone in type 1 diabetic patients under insulin pump therapy: the PumpNet study. Diabetes Metab. 2007;33(3):220–6.CrossRefGoogle Scholar
  27. 27.
    Montori VM, Helgemoe PK, Guyatt GH, Dean DS, Leung TW, Smith SA, et al. Telecare for patients with type 1 diabetes and inadequate glycemic control: a randomized controlled trial and meta-analysis. Diabetes Care. 2004;27(5):1088–94.CrossRefGoogle Scholar
  28. 28.
    Bergenstal RM, Bashan E, McShane M, Johnson M, Hodish I. Can a tool that automates insulin titration be a key to diabetes management? Diabetes Technol Ther. 2012;14(8):675–82.CrossRefGoogle Scholar
  29. 29.
    Charpentier G, Benhamou P-Y, Dardari D, Clergeot A, Franc S, Schaepelynck-Belicar P, et al. The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study). Diabetes Care. 2011;34(3):533–9.CrossRefGoogle Scholar
  30. 30.
    Jeandidier N, Chaillous L, Franc S, Benhamou PY, Schaepelynck P, Hanaire H, Catargi B, Farret A, Fontaine P, Guerci B, Reznik Y, Penfornis A, Borot S, Serusclat P, Kherbachi Y, D’Orsay G, Detournay B, Simon P, Charpentier G. DIABEO app software and telemedicine versus usual follow-up in the treatment of diabetic patients: protocol for the TELESAGE randomized controlled trial. JMIR Res Protoc. 2018;7(4):e66.CrossRefGoogle Scholar
  31. 31.
    Whitehead L, Seaton P. The effectiveness of self-management mobile phone and tablet apps in long-term condition management: a systematic review. J Med Internet Res. 2016;18(5):e97.CrossRefGoogle Scholar
  32. 32.
  33. 33.
    Lee J. Hype or hope for diabetes mobile health applications? Diabetes Res Clin Pract. 2014;106(2):390–2.CrossRefGoogle Scholar
  34. 34.
    Rasekaba TM, Furler J, Blackberry I, Tacey M, Gray K, Lim K. Telemedicine interventions for gestational diabetes mellitus: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2015;110(1):1–9.CrossRefGoogle Scholar
  35. 35.
    Harris MA, Freeman KA, Duke DC. Seeing is believing: using skype to improve diabetes outcomes in youth. Diabetes Care. 2015;38(8):1427–34.CrossRefGoogle Scholar
  36. 36.
    Petrovski G, Zivkovic M, Stratrova SS. Social media and diabetes: can Facebook and Skype improve glucose control in patients with type 1 diabetes on pump therapy? One-year experience. Diabetes Care. 2015;38(4):e51–2.PubMedGoogle Scholar
  37. 37.
    Dougherty JP, Lipman TH, Hyams S, Montgomery KA. Telemedicine for adolescents with type 1 diabetes. West J Nurs Res. 2014;36(9):1199–221.CrossRefGoogle Scholar
  38. 38.
    Kassar K, Roe C, Desimone M. Use of telemedicine for management of diabetes in correctional facilities. Telemed J E Health. 2017;23(1):55–9.CrossRefGoogle Scholar
  39. 39.
    Frederick S. The key to making telemedicine work. Health Manag Technol. 2013;34(4):12.PubMedGoogle Scholar
  40. 40.
    Franc S, Borot S, Ronsin O, Quesada J-L, Dardari D, Fagour C, et al. Telemedicine and type 1 diabetes: is technology per se sufficient to improve glycaemic control? Diabetes Metab. 2014;40(1):61–6.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Centre for Study and Research for Improvement of the Treatment of Diabetes (CERITD)Evry CedexFrance
  2. 2.Department of DiabetesSud-Francilien HospitalCorbeil-EssonnesFrance

Personalised recommendations